HYPERION THERAPEUTICS INC (HPTX) [Rocket]

In millions, except per share items	Dec-31-14	Dec-31-13	Dec-31-12	Nov-01-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08
	10-K	10-K	10-K	10-K/A	10-K	10-K/A	S-1/A	10-K/A
Net product revenue	113.6	42.2	28.8		26.6
Net product revenue growth	169.1%	46.4%	8.6%
Costs and expenses:
Cost of sales	13.7	6.7
Research and development	20.7	10.0	17.0		17.2
Selling, general and administrative	48.5	35.8	11.5		8.9
Amortization of intangible asset	4.6	3.1
Total costs and expenses	131.5	62.4	57.4		52.7
Income from operations	-4.2	-13.4	-28.5		-26.2
Operating margin	100.0%	100.0%	-99.0%		-98.5%
Interest income	0.6	0.0	0.0		0.0
Interest expense	-1.6	-1.5	-3.7		-2.6
Other income (expense), net (Notes 4 and 10)	-0.7	0.5	0.0		-0.7
Income before income taxes	-6.0	16.7	-32.3		-29.4
Income tax expense	0.3	0.0
Net income	-6.3	16.6	-32.3		-29.4			-29.1

Net income per share:
Basic	($0.31)	$0.86	($4.45)		($62.68)
Diluted	($0.31)	$0.80	($4.45)		($62.68)

Weighted average number of shares used to compute net income per share of common stock:
Basic	20.5	19.4	7.3		0.5
Diluted	20.5	20.7	7.3		0.5